MedPath

Two Versus Four Weeks of Antibiotic Treatment in Native Joint Arthritis

Not Applicable
Completed
Conditions
Arthritis, Septic
Interventions
Procedure: Two week's arm - surgery
Procedure: Four week's arm - surgery
Drug: Two week's arm - drugs
Drug: Four week's arm - drugs
Registration Number
NCT03615781
Lead Sponsor
University Hospital, Geneva
Brief Summary

The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allowing up to 3 surgical lavages and allocating patients into a two-week's and a four week's randomization arm

Detailed Description

The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allocating patients into a two-week's and a four week's randomization arm.

The adult patients are hospitalized for septic arthritis. A computer program randomizes 1:1 between a two week's and a four week's arm of targeted antibiotic treatment of which at least the first week is intravenously. The randomization may occur until Day 5 of admission. Up to three surgical interventions are allowed. The investigators allow the inclusion of all bacterial arthritis and all joints.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
85
Inclusion Criteria
  1. Age >17 years
  2. Microbiologically-confirmed septic arthritis
  3. At least one surgical drainage/lavage
Exclusion Criteria
  1. Presence of osteosynthesis material in the vicinity of the articulation
  2. Presence of a concomitant infection needing more than 2 week's of antibiotic therapy
  3. More than 3 surgical drainages
  4. Life expectancy less than 6 months
  5. Chronic osteomyelitis in vicinity of the arthritis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Two week's arm - surgeryTwo week's arm - surgeryThe investigators perform a surgical drainage and removal of the infected orthopedic implant.
Four week's arm - surgeryFour week's arm - surgeryThe investigators surgically remove the infected implant.
Two week's arm - drugsTwo week's arm - drugsThe investigators perform a surgical drainage and removal of the infected orthopedic implant. They start an empirical antibiotic treatment based on patient's history and co-morbidities, such as vancomycin or amoxicillin/clavulanic acid. The adapt later on the targeted antibiotic therapy according to the causative pathogens and their antibiotic susceptibility testing.
Four week's arm - drugsFour week's arm - drugsThe investigators surgically remove the infected implant and all soft tissue infection. Instead of a total of 2 week's of antibiotic therapy, they administer a total of 4 weeks of systemic antibiotic therapy targeted to the pathogen(s).
Primary Outcome Measures
NameTimeMethod
Clinical Remission of systemic infection6 months

Measurement of fever.

Sequels6 months

Patient's remaining gait disorders.

* range of movement in adjacent joints of former infection

* questionnaire regarding persistant pain and handicaps (open wording)

Secondary Outcome Measures
NameTimeMethod
Presence of pus6 months

Visual examination of the presence of pus coming out the wound

Wound redness6 months

Visual examination of the presence of wound redness.

Wound discharge6 months

Visual examination of the presence of wound discharge

Trial Locations

Locations (1)

Geneva University Hospitals

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath